MARK4 and breast carcinoma: We focussed on investigating whether MARK4 down‐regulation mediated the migratory effects of miR‐515‐5p because this target was most dramatically decreased by miR‐515‐5p overexpression in breast cancer (Fig 2B and C) and had previously been involved in microtubule dynamics 6.